FDA Slammed For Silence On ADHD Warning Labels

Law360, New York (August 25, 2006, 12:00 AM EDT) -- A U.S. Senator has criticized the U.S. Food and Drug Administration’s decision to require heart and psychiatric warnings on attention deficit drugs without making a public announcement.

Sen. Chuck Grassley (R-Iowa) said the organization should have been more forthcoming.

“The risk factors that prompted the new warnings are obviously very serious, and millions of adults and children take these drugs. Doctors, parents and patients deserved to hear about the changes. They shouldn’t have to search high and low for information. It’s of great concern if the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.